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INTRODUCTION
Human reproductive failure is as old as mankind. This
public health problem involves all regions of the world
and its prevalence worldwide varies from 10-15%1;
10-32% in Africa2 and 31.5% in Nigeria3. The various
categories of human reproductive failure include:
infertility, recurrent pregnancy loss (spontaneous
miscarriages or abortions and preterm birth) and
ectopic pregnancy. Causes include environmental and
life style factors, congenital malformations, endocrine
disorders, immunologic abnormalities and sequelae of
genital tract infections4,5.
The association of infertility with genital tract infections
(GTIs) or sexually transmitted infections has been
demonstrated. GTIs associated with human
reproductive failure include: Treponema pallidum, Neisseria
gonorrheae, Chlamydia trachomatis, Trichomonas vaginalis and
Schistosoma haematobium infections among others. The
spread of gonococcal and Chlamydial infection to
upper female genital tract may cause pelvic
inflammatory disease with severe tubal scarring leading
to tubal infertility6. Genital tract infections evoke both
cellular and humoral immune response leading to
activation of polymorphonuclear leucocytes,
macrophages and the release of  cytokines. These
immunologic factors produced in response to GTIs
influence various aspects of reproduction including
follicle development, ovulation, luteinisation, oocyte
quality, fertilization, implantation, foetal development
and pregnancy immunotolerance 7-9. Abnormal
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ABSTRACT
Background: Genital tract infections and obesity are both
sources of oxidative stress. Alterations in immune and
antioxidant parameters may arise from this or from an
indeterminate autoimmune mechanism.
Objective: This study aimed to investigate the association of
Chlamydial infection, obesity and oxidative response with tubal
infertility in Nigerian women.
Methods: It was a case-control study of 40 women with tubal
infertility and 32 fertile women, respectively, recruited from
the Infertility and Family Planning Clinics respectively, of  the
University College Hospital, Ibadan, Nigeria. Anthropometric
indices were measured in each subject and endocervical swabs
were taken to screen for current genital tract infection.
Antioxidant, hormonal and immunologic analysis were
performed on serum.
Results: None of the subjects had current genital tract
infections. Chlamydia trachomatis IgG positivity was
significantly higher in infertile than in fertile subjects [OR
4.33; 95%CI (0.078-0.681)]. No significant variations were
observed in the anthropometric indices, antioxidant parameters
and hormones between infertile and the fertile women. Body
mass index correlated positively with oxidative stress in
infertile subjects. Waist and hip circumferences correlated
negatively with oestradiol in women with tubal infertility.
Conclusion: Chlamydial infection is associated with tubal
factor infertility, however, obesity seems to increase oxidative
stress and reduce fertility potential in women with tubal factor
infertility.
Key words: Tubal infertility, obesity, oxidative stress, Chlamydia
ORIGINAL ARTICLE Ann Ibd. Pg. Med 2011. Vol.9, No.2 83-88
                                                   Annals of Ibadan Postgraduate  Medicine. Vol. 9 No. 2 December, 2011  83
immunologic profile which in part is characterized by
autoantibody abnormalities have been described in
infertile women10. GTIs induce increased production
of reactive oxygen species and nitric oxide leading to
oxidative stress which has been implicated in the
pathophysiology of  tubal and peritoneal factor
infertility, endometriosis, preeclampsia, hydatidiform
mole, free radical-induced birth defects and
abortions11-16.  Their pathological effects are exerted
by various mechanisms including lipid peroxidation,
peroxidative DNA damage, mitochondrial alterations
and apoptosis17. The complex interplay between GTI
and its induction of oxidative stress and pathologic
immune response both systemic and locally and the
deleterious effects of these responses on the male and
female genital tract which include tissue damage, tubal
scarring, pelvic inflammatory disease, chronic salpingitis,
endometritis and distal tubal obstruction have been
implicated as pathologic mechanisms of  infertility.
Excessive weight and central distribution of body fat
have been related to an increased risk of
normogonadotrophic anovulation18. High body mass
index (BMI) has been implicated in development of
insulin resistance and hyperinsulinaemia.  Elevated
insulin levels have been reported to inhibit the
conversion of testosterone to oestrogen. Lower levels
of oestrogen will lead to anovulation and infertility19.
Obesity appears to have a major impact on
reproductive performance and can compromise it in
a variety of ways; including menstrual disorders and
anovulation. Weight reduction in obese patients reduces
hyperandrogenism and hyperinsulinaemia; both of
which factors influence the ovarian response to
follicular stimulating hormone. Weight loss can re-
establish ovulation in obese anovulatory patients or
improve their response to ovulation induction. Clark
et al. 20 in 1995 found that weight loss re-established
ovulation in obese anovulatory patients or improved
their response to ovulation induction: in a series of 67
anovulatory women, 90% resumed ovulation after
weight loss and 78% conceived. The same study group
confirmed these findings in a larger series21. Similar
results were obtained in preliminary observations by
Crosignani et al., 1999 22 and 2002 23. In another series,
among the 27 out of 33 patients with irregular
menstrual cycles who lost weight, 18 re-established
regular cycles 18. A total of 60% had ovulatory levels
of  plasma progesterone after weight loss. Neither
menstrual cycle improvement, nor ovulatory values of
progesterone nor pregnancies occurred in the eight
patients who did not lose weight. Therefore, it is
presumed that obesity may be responsible for the
relative ovarian insensitivity to infertility treatment18.
This study aimed to investigate the association of
Chlamydial infection, obesity and oxidative response
with tubal infertility in Nigerian women.
MATERIALS AND METHODS
Study design
This case control study was conducted in the University
College Hospital (UCH), Ibadan, Nigeria. It served as
a pilot for an on-going larger work studying the
association of oxidative stress and pathologic response
to stress with infertility. The study population
comprised of female patients of reproductive age
attending the Infertility Clinic and a control group of
age-matched fertile women who were new clients at
the Family Planning Clinic. The study protocol was
approved by UI/UCH Ethical Committee (Ref UI/
EC/08/0083).
Hypothesis
The hypothesis was that tubal infertility is not associated
with oxidative stress and obesity. The outcome
measures were the anthropometric and oxidative stress
parameters of  the subjects.
Selection of Subjects
Forty consenting women with infertility of  at least one
year’s duration (with tubal blockage identified by
hysterosalpingography) were recruited from the
infertility clinic, while 32 controls were recruited from
the family planning clinic. The controls were women
without previous infertility who had childbirth within
the last two years, and who had not been on any form
of contraception prior to recruitment. Exclusion
criteria included women that were undergoing any form
of  contraceptive therapy, previous history of  uterine
surgery, malignancy, long term medication, chronic
organ or systemic illness and those who did not give
consent.
Anthropometric indices (height, weight, waist and hip
circumferences) were taken to calculate the body mass
index and waist-hip ratio (WHR) respectively.
Sample Collection
Ten millilitres of  venous blood samples were collected
aseptically from each subject on days 3-5 and 21-23
of  a 28-30 day menstrual cycle, respectively. The
samples were dispensed into universal containers. After
clot retraction, the samples were centrifuged at 3000
rev/s for ten minutes after which serum was extracted
and stored in small aliquots at -20oC. High vaginal
swabs (HVS) and endocervical swabs (ECS) were also
taken from all subjects of study using sterile swab sticks
for detection of common sexually-transmitted
infections.
                                                   Annals of Ibadan Postgraduate  Medicine. Vol. 9 No. 2 December, 2011  84
Laboratory Methods
Endocrinological analysis: follicular stimulating
hormone (FSH), luteinizing hormone (LH),
progesterone (P4), estradiol (E2) and prolactin (PRL)
were measured with enzyme immunoassay method
(EIA) from Immunometrics Ltd., London, UK.
Antioxidant profile: total antioxidant potential (TAP)
was estimated using the ferric reducing antioxidant
power (FRAP) method of  Benzie and Strain24. Total
plasma peroxides (TPP), as a biomarker of Oxidative
Stress (OS), were estimated using the modified FOX
2 method of  Harma et al.25. Oxidative stress index
(OSI) was calculated as a ratio of  TPP/TAP.
Microbiological Analysis: screening for Trichomonas
vaginalis was by microscopy while Neisseria gonorrheae
was by gram staining, followed by culture if  necessary.
Immunologic analysis: endocervical swabs were tested
for Chlamydia trachomatis antigen with a rapid screening
test (DiaSpot™, Bresta Perkasa, Indonesia). Serum was
screened for Treponema pallidum antibodies (IgG & IgM)
by immunochromatographic method with Exact®
syphilis diagnostic device, USA; and Chlamydia
trachomatis antibodies (CT IgG) with ImmunoComb®,
Orgenics Ltd., Yavne, Israel.
Statistical Analysis
Data was analyzed using the statistical package of social
science (SPSS) software 15.0 version. For quantitative
variables, paired student’s t-test was used to test for
mean differences. Pearson’s correlation analysis was
employed to determine associations between variables.
For non-quantitative variables,  -square analysis was
used for determination of  associations between
variables. Significant p was <0.05.
RESULTS
The screening tests for the afore-mentioned were all
negative, suggesting that none of  the patients had
current genital tract infection. Chlamydial antibodies
were further tested for; to identify women with
previous infection which may have led to the tubal
damage. Table 1 shows the comparison of  Chlamydia
trachomatis IgG (CT IgG) antibody positivity in fertile
and infertile women. The fertile group of the study
population were significantly less likely to have
Chlamydia trachomatis antibodies than the infertile
group [OR=4.33; 95%CI (0.078-0.681)].
Table 2 shows the comparison of  anthropometric data,
hormone profiles and antioxidant parameters among
fertile and infertile women; luteinizing hormone was
significantly higher in the infertile group.
The correlation of anthropometric indices with
oxidative stress and hormonal parameters showed that
BMI had a significant positive correlation with TPP
(p<0.001) and OSI (p-0.001) in the infertile group but
not in controls. In infertile women, waist circumference
(p-0.006) and hip circumference (p<0.001), respectively,
correlated negatively with oestrogen.
DISCUSSION
The total antioxidant potential (TAP), total plasma
peroxides (TPP) and therefore, oxidative stress index
(OSI) were not significantly different between infertile
women and their fertile controls. This finding is in
agreement with other authors, who reported no
significant differences in TAP in infertile and fertile
controls26,27. Total plasma peroxides were positively
associated with BMI; this indicated that increasing BMI
may be a risk factor for increased oxidative stress and
the associated deleterious effects on the general body
system. Oxidative stress has been implicated in the
pathogenesis of more than 100 disease conditions
including infertility16. The place of obesity in
anovulatory infertility has been discussed—however,
the subjects of the current study were ovulating, as
observed by their mid-luteal progesterone assays. This
finding suggests that BMI may increase oxidative stress
and its influence on infertility in the absence of
anovulation.
The negative correlation observed between oestradiol
and waist and hip circumferences imply that obesity in
women may lead to a hormonal imbalance that may
reduce their fertility. It has been reported that ovulating
subfertile women with a BMI over 29 kg/m2 have
lower pregnancy rates compared with those with
normal weight28. Our study also points to this fact as
indicated by the increased oxidative stress.
Infertile (n=40) Fertile (n=32) Total
CT IgG +ve
Subjects 20 6 26
% 50.0 18.3
CT IgG-ve
Subjects 20 26 46
% 50.0 81.7
40 32 72
OR=4.33, 95%CI (0.078-0.681)
χ2=7.847, df=1, P=0.005
CT IgG= Chlamydia trachomatis immunoglobulin G
+ve = Positive
-ve = Negative
Table 1: Comparison of  Chlamydia trachomatis IgG
(CTIgG) antibody positivity in Fertile and Infertile Women
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We did not expect the fertility hormone profile to be
significantly different between infertile and fertile
women in this study; the profile was studied to ascertain
that the cases did not have anovulatory infertility, which
could be a confounder. The only isolated significant
hormone was luteinizing hormone. The current study
cannot fully explain the association; however, the mid-
luteal progesterone suggested these women were
actually ovulating—therefore, the elevated LH may be
of little consequence. The study design did not allow
for testing mid-luteal progesterone in the controls. We
required these fertile controls to be contraceptive- and
hormone-naïve, so they were recruited at their first
visit to family-planning clinic. A mid-luteal
progesterone assay would have required a follow-up
visit, but by this time, they would have been
Index
Infertile
n = 40
Fertile
n= 32 t p
Age (yrs) 32.3±4.0 33.5±4.8 -1.185 0.240
Weight (kg) 69.2±11.4 66.1±14.4 1.019 0.312
Height (m) 1.6 ± 0.1 1.6 ± 0.1 0.423 0.673
BMI (kg/m2) 27.1±0.4 26.1±5.1 0.879 0.382
WC (cm) 84.9±8.3 84.4±12.4 0.179 0.858
HC (cm) 103.7±9.6 103.0±12.4 0.272 0.786
WHR 0.82±0.0 0.82±0.1 -0.027 0.979
TAP (μmol TE/L) 767.9±146.8 748.9±90.2 0.643 0.522
TPP
(μmol H2O2/L) 6.3±7.8 4.4±1.4 1.337 0.185
OSI 0.9±0.9 0.6±0.2 1.569 0.121
FSH (IU/L) 13.4±11.8 10.1±4.7 1.462 0.148
LH (IU/L) 16.1±21.2 5.7±3.9 2.712 0.008
Prolactin (IU/L) 452.2±486.2 611±874.9 -0.976 0.332
P4 (pmol/L)* 22.6±19.8 - 3.264 -
E2 (pmol/L) 0.85±1.87 0.51±0.41 1.000 0.321
*see text for explanation1
BMI- body mass index, WC-waist circumference, HC-hip circumference, WHR- waist-hip ratio, TAP- total antioxidant potential, TPP-
total plasma peroxides, OSI- oxidative stress index, FSH-follicular-stimulating hormone, LH-luteinizing hormone, P4-progesterone, E2-
oestrogen
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commenced on a contraceptive method, so would
not be suitable for inclusion any longer. The relatively
high values of prolactin in the fertile women were
probably because most of them were still nursing their
infants at the time of recruitment. The prevalence of
Chlamydia antibody positivity was found to be
significantly higher in infertile women compared to
their fertile controls. This finding is in agreement with
the findings of other workers 3,29-34. Chlamydial
infection evokes pathologic immune response and
generation of reactive oxygen species which results in
inflammatory response, apoptosis, tissue damage,
scarring, fibrosis, hydrosalpinx, tubal occlusion leading
to tubal infertility16.
The findings of this study may be limited by the small
sample size; the association of obesity with tubal
infertility may be validated in the larger study to follow.
The study will include evaluation of cellular as well as
humoral pathologic response found associated with
tubal infertility, and will hopefully shed more light on
the aetiopathogenesis of  infertility.
CONCLUSION
Previous Chlamydial infection is significantly associated
with tubal factor infertility. Obesity seems to reduce
fertility potential in women with tubal factor infertility
as well as increase oxidative stress. Larger studies are
required to explore this.
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